the business relationship between mr stang and mr glueck was dissolved in september 1997 when the second respondent (mr kritzler) purchased the shares held in novapharm by mr glueck and mr glueck's daughter.
counsel for the first, second, third and fifth respondents: mr j m ireland qc and mr j s cooke solicitor for the first, second, third and fifth respondents: spruson &amp; ferguson lawyers date of hearing: 18 february 2008 date of judgment: 27 february 2008 austlii: copyright policy | disclaimers | privacy policy | feedback url: http://www.austlii.edu.au/au/cases/cth/fca/2008/148.html
introduction 1 this proceeding relates to an invention (the invention) the subject of australian patent no 729662 (the patent) and united states patent no 6,531,434 (the us patent).